TLR4 and salmonellosis: Potential immunomodulating treatment strategies for invasive Salmonellosis could target the pathogen directly (e.g., based on drugs targeting T3SS or flagella) or target key host response proteins (e.g., TLR4, NLRC4, or IL-1β) depending on the phase of the immune response.